118 related articles for article (PubMed ID: 2274062)
1. Lack of tumorigenicity of interleukin 4 autocrine growing cells seems related to the anti-tumor function of interleukin 4.
Li WQ; Diamantstein T; Blankenstein T
Mol Immunol; 1990 Dec; 27(12):1331-7. PubMed ID: 2274062
[TBL] [Abstract][Full Text] [Related]
2. Retroviral interleukin 4 gene transfer into an interleukin 4-dependent cell line results in autocrine growth but not in tumorigenicity.
Blankenstein T; Li WQ; Müller W; Diamantstein T
Eur J Immunol; 1990 Apr; 20(4):935-8. PubMed ID: 2347369
[TBL] [Abstract][Full Text] [Related]
3. Retroviral interleukin 5 gene transfer into interleukin 5-dependent growing cell lines results in autocrine growth and tumorigenicity.
Blankenstein T; Li WQ; Uberla K; Qin ZH; Tominaga A; Takatsu K; Yamaguchi N; Diamantstein T
Eur J Immunol; 1990 Dec; 20(12):2699-705. PubMed ID: 2269330
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer.
Blankenstein T; Qin ZH; Uberla K; Müller W; Rosen H; Volk HD; Diamantstein T
J Exp Med; 1991 May; 173(5):1047-52. PubMed ID: 2022919
[TBL] [Abstract][Full Text] [Related]
5. Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response.
Qin Z; Blankenstein T
Cancer Res; 1995 Nov; 55(21):4747-51. PubMed ID: 7585497
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.
Ohira T; Ohe Y; Heike Y; Podack ER; Olsen KJ; Nishio K; Nishio M; Miyahara Y; Funayama Y; Ogasawara H
J Cancer Res Clin Oncol; 1994; 120(11):631-5. PubMed ID: 7962038
[TBL] [Abstract][Full Text] [Related]
7. Expression of genes containing the IgH enhancer in non-lymphoid cells.
Klein BY; Morrison SL
Mol Immunol; 1990 Aug; 27(8):713-22. PubMed ID: 2119478
[TBL] [Abstract][Full Text] [Related]
8. Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model.
Menssen HD; Harnack U; Erben U; Neri D; Hirsch B; Dürkop H
J Cancer Res Clin Oncol; 2018 Mar; 144(3):499-507. PubMed ID: 29327244
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma.
Kopantzev E; Roschke V; Rudikoff S
Hum Gene Ther; 1998 Jan; 9(1):13-9. PubMed ID: 9458238
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.
Hock H; Dorsch M; Kunzendorf U; Qin Z; Diamantstein T; Blankenstein T
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2774-8. PubMed ID: 8464888
[TBL] [Abstract][Full Text] [Related]
11. The secondary antigen-specific IgE response in murine lymphocytes is resistant to blockade by anti-IL4 antibody and an antisense oligodeoxynucleotide for IL4 mRNA.
Haruna K; Hikida M; Ohsugi Y; Ohmori H
Cell Immunol; 1993 Oct; 151(1):52-64. PubMed ID: 8402931
[TBL] [Abstract][Full Text] [Related]
12. Increased frequency of interleukin 4-producing T cells as a result of polyclonal priming. Use of a single-cell assay to detect interleukin 4-producing cells.
Seder RA; Le Gros G; Ben-Sasson SZ; Urban J; Finkelman FD; Paul WE
Eur J Immunol; 1991 May; 21(5):1241-7. PubMed ID: 1828031
[TBL] [Abstract][Full Text] [Related]
13. Production of interleukin 2 and interleukin 4 by immune CD4-CD8+ and their role in the generation of antigen-specific cytotoxic T cells.
Horvat B; Loukides JA; Anandan L; Brewer E; Flood PM
Eur J Immunol; 1991 Aug; 21(8):1863-71. PubMed ID: 1907920
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between rejection of tumor cells co-expressing interleukin-2 and B7.1 and vaccine efficiency.
Cayeux S; Richter G; Becker C; Beck C; Aicher A; Pezzutto A; Dörken B; Blankenstein T
Eur J Immunol; 1997 Jul; 27(7):1657-62. PubMed ID: 9247574
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen.
Treisman J; Hwu P; Minamoto S; Shafer GE; Cowherd R; Morgan RA; Rosenberg SA
Blood; 1995 Jan; 85(1):139-45. PubMed ID: 7803791
[TBL] [Abstract][Full Text] [Related]
16. In vitro growth of TS/A adenocarcinoma and of the gene transfected TS/A-IL4 line on biological substrates.
Pacor S; Magnarin M; Carotenuto ME; Spessotto P; Zabucchi G; Sava G
Anticancer Res; 2000; 20(1A):191-6. PubMed ID: 10769654
[TBL] [Abstract][Full Text] [Related]
17. Paracrine effects of IL-4 transfection on TS/A adenocarcinoma cells mediate reduced in vivo growth.
Pacor S; Gagliardi R; Spessotto P; Zabucchi G; Sava G
Pathol Oncol Res; 1999; 5(2):110-6. PubMed ID: 10393362
[TBL] [Abstract][Full Text] [Related]
18. Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells.
Ohe Y; Podack ER; Olsen KJ; Miyahara Y; Ohira T; Miura K; Nishio K; Saijo N
Int J Cancer; 1993 Feb; 53(3):432-7. PubMed ID: 8428797
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of interleukin-4 and B7.1 in murine tumor cells leads to improved tumor rejection and vaccine effect compared to single gene transfectants and a classical adjuvant.
Cayeux S; Beck C; Dörken B; Blankenstein T
Hum Gene Ther; 1996 Mar; 7(4):525-9. PubMed ID: 8800747
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of growth autonomy and tumorigenicity by an interleukin 6-dependent human myeloma cell line transfected with interleukin 6 cDNA.
Okuno Y; Takahashi T; Suzuki A; Fukumoto M; Nakamura K; Fukui H; Koishihara Y; Ohsugi Y; Imura H
Exp Hematol; 1992 May; 20(4):395-400. PubMed ID: 1568457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
